Association of lipid-lowering drug treatment with all-cause and cardiovascular mortality among people aged 75 years and above without cardiovascular disease: evidence from a cohort study

Back

ESC2025 Premium Access

Association of lipid-lowering drug treatment with all-cause and cardiovascular mortality among people aged 75 years and above without cardiovascular disease: evidence from a cohort study

Session: Drug therapy (2)

Topic: Drug therapy

Speaker: Assistant Professor Z. Yang (Shatin, HK)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Assistant Professor Zuyao Yang

The Chinese University of Hong Kong, Shatin (Hong Kong)

0 follower

7 more presentations in this session

Bempedoic acid in clinical practice.

Speaker: Doctor J. Vazquez Reguera (Las Palmas de Gran Canaria, ES)

Efficacy and safety of Alirocumab once-monthly dosing in patients with atherosclerotic cardiovascular disease and without acute coronary syndrome or stroke; an ODYSSEY CHOICE I analysis

Speaker: Doctor C. Bonanad Lozano (Valencia, ES)

Efficacy and safety of add on bempedoic acid on maximal dose of rosuvastatin and ezetimibe in patients with established coronary artery disease (ADDBAMPIRE study)

Speaker: Professor N. Garg (Lucknow, IN)

LDL on target - strike early and strike strong... just strike...

Speaker: Doctor L. Hamann (Faro, PT)

VICTORION IMPLEMENT: an observational study of the lipid management landscape in Germany

Speaker: Professor O. Weingaertner (Jena, DE)

Access the full session

Drug therapy (2)

Speakers: Assistant Professor Z. Yang, Doctor J. Vazquez Reguera, Doctor C. Bonanad Lozano, Professor N. Garg, Doctor L. Hamann...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources